Author:
Dakal Tikam Chand,Kakde Ganesh S.,Maurya Pawan Kumar
Publisher
Springer Science and Business Media LLC
Reference182 articles.
1. Amirpour Z, Bahari A, Nafisi B, Rahmani K, Taghipour Zahir S, Shahid Sadoughi General Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. (2020) Prognosis and survival study in patients with Glioblastoma Multiform and its relationship with EGFR expression. Iran J Neurosurg 6(3):113–120. https://doi.org/10.32598/irjns.6.3.2
2. Amit D, Matouk IJ, Lavon I, Birman T, Galula J, Abu-Lail R, Schneider T, Siegal T, Hochberg A, Fellig Y (2012) Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters. Int J Clin Exp Med 5(2):124–135
3. An Z, Aksoy O, Zheng T, Fan Q-W, Weiss WA (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37(12):1561–1575. https://doi.org/10.1038/s41388-017-0045-7
4. Andersson ER, Sandberg R, Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138(17):3593–3612. https://doi.org/10.1242/dev.063610
5. Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126(2):267–276. https://doi.org/10.1007/s00401-013-1141-6